Pulmonary Surfactant Treatment for Preterm Infants With Respiratory Distress Syndrome: A Nationwide Survey
Haifeng Zong, Chuanzhong Yang, Long Chen, Yong Ji, Rong Ju, Jiangqin Liu, Ling Liu, Jingyun Shi, Hui Wu, Lili Wang, Falin Xu, Huayan Zhang, Yuan Shi, MUNICH Study Group · 2026
Read Pulmonary Surfactant Treatment for Preterm Infants With Respiratory Distress Syndrome: A Nationwide Survey by Haifeng Zong, Chuanzhong Yang, Long Chen, Yong Ji, Rong Ju, Jiangqin Liu, Ling Liu, Jingyun Shi, Hui Wu, Lili Wang, Falin Xu, Huayan Zhang, Yuan Shi, MUNICH Study Group (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13534843.txt.
Description
Thirteen authors plus a study group survey lung coat use for preterm babes in China in a 2026 poll. One lung lead from each of 394 hospitals in 30 zones filled the web form in late 2022. Marks span stock, dose, time, and path of the coat drug for breath ill babes. Wide gaps form the core find.
The drug sat in 96.7 percent of hospitals, yet in just half of birth rooms in the poll. First dose came at a mid two hours post birth in most reports. Soft paths to give the drug sat in half of sites. Set drills are urged.
Catalog record
| CREATOR | Haifeng Zong, Chuanzhong Yang, Long Chen, Yong Ji, Rong Ju, Jiangqin Liu, Ling Liu, Jingyun Shi, Hui Wu, Lili Wang, Falin Xu, Huayan Zhang, Yuan Shi, MUNICH Study Group |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |